Stocks and InvestingStocks and Investing
Tue, April 5, 2022
Mon, April 4, 2022
Sun, April 3, 2022
Fri, April 1, 2022
Thu, March 31, 2022

David Dai Initiated (ACET) at Buy and Held Target at $28 on, Mar 31st, 2022


Published on 2024-10-27 20:14:55 - WOPRAI, David Dai
  Print publication without navigation


David Dai of SMBC Nikko, Initiated "Adicet Bio, Inc." (ACET) at Buy and Held Target at $28 on, Mar 31st, 2022.

David has made no other calls on ACET in the last 4 months.



There are 4 other peers that have a rating on ACET. Out of the 4 peers that are also analyzing ACET, 0 agree with David's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with David


  • Reni Benjamin of "JMP Securities" Maintained at Buy with Decreased Target to $21 on, Thursday, March 17th, 2022
  • Asthika Goonewardene of "Truist Securities" Initiated at Strong Buy and Held Target at $30 on, Tuesday, March 8th, 2022
  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $27 on, Friday, March 4th, 2022
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Increased Target to $32 on, Monday, December 6th, 2021